SCOPUS
SKIN: Journal of Cutaneous Medicine
National Society for Cutaneous Medicine, United States
SKIN: Journal of Cutaneous Medicine is an academic journal published by National Society for Cutaneous Medicine (United States). Identifiers: eISSN 2574-1624. Indexed in SCOPUS. Metrics: CiteScore 0.4, SJR 0.152, SNIP 0.10. tlooto lists 515 papers from this journal.
CiteScore
0.40
Scopus citation metric
SJR
0.152
SCImago rank
SNIP
0.10
Source normalized impact
Percentage rank
-
JIF percentile rank
Journal profile
- ISSN
- -
- eISSN
- 2574-1624
- Abbreviation
- -
- Publisher
- National Society for Cutaneous Medicine
- Country
- United States
Web of Science categories
No Web of Science category data available.
Scopus ASJC categories
2708 Dermatology
Papers in this journal
Recent papers
- Disparities in Malignant Melanoma Diagnosis in American Indian/Alaska Native Versus White Patients
2026
- Integrating 31-Gene Expression Profiling in a Spitzoid Melanocytic Lesion: A Case Report in a 24-Year-Old Patient
2026
- Effectiveness and Safety of Montelukast as an Adjuvant Therapy to Isotretinoin Treatment of Acne Vulgaris: A Randomized Controlled Trial
2026
- Characteristics of Best-Selling Topical Pain Relief Medications at Major Online Retailer
2026
- Safety of Intramuscular Triamcinolone Injections for Hidradenitis Suppurativa Flares: Findings from a Retrospective Cohort Study
2026
Most cited papers
- Navigating the Transition: The Impact of Step/Level 1 Pass/Fail Grading on Dermatology Residency Match Outcomes
2025 · 5 citations
- The Impact of Chronic Hand Eczema on Occupation, Work Productivity, and Activity Impairment – Results From the CHECK Study in the United States
2025 · 3 citations
- Flexible Dosing of Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis: Initial Results From the Real-World–Simulating Expanded Access Protocol Study, JADE REAL
2025 · 2 citations
- KT-621, an Oral, Once Daily, Targeted STAT6 Degrader: First-in-Human Phase 1a Safety, Pharmacokinetics, Pharmacodynamics and Th2 Biomarker Effects
2025 · 2 citations
- Upadacitinib for Pyoderma Gangrenosum: A Case Report and Review of Emerging Evidence
2025 · 2 citations